Clinical Trial Imaging Market - Trends, Outlook, and Opportunity Analysis, 2019-Posted by Shristi on March 20th, 2020 Analyst Speak:
“The Global Clinical Trial Imaging Market was valued around US$ 821.8 Bn by 2018 and growing at a significant CAGR of 7.2% over next seven years 2019-2025 due to growth in the pharmaceutical and biotechnology industries” The global clinical trial imaging market accounted for US$ 821.8 Bn in 2018 and burgeoning over the forthcoming years. Some of thе key factors fueling the market growth include growth in the pharmaceutical and biotechnology industries, huge spending on R&D, rise in number of contract research organizations and advancements in the technology. Also, enhanced investment in medical imaging companies and adoption of innovative imaging technologies to support clinical trials are other factors responsible for the market growth. However, high implementation cost of imaging systems and high capital required to run clinical trials are hindering the market growth. Global clinical trial imaging market segmented on the basis of product & services, modality, end-user and region. Request for sample report @ https://www.precisionbusinessinsights.com/request-sample?product_id=38750
Based on modality, global clinical trial imaging market segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, x-ray, echocardiography and other modalities. Computed Tomography held considerable market share during forecast period. Computed tomography (CT) is a diagnostic imaging test used to create detailed images of internal organs, bones, soft tissue and blood vessels. Modern CT machines take continuous pictures in a helical fashion rather than taking a series of pictures of individual slices of the body, as the original CT machines did. North America Leads the Global Clinical Trial Imaging market PBI’s global Clinical Trial Imaging market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. North America accounted for larger revenue share in global clinical trial imaging market with considerable CAGR. The growth in this region is due to increasing geriatric population together with rising prevalence of chronic diseases and growing number of pharmaceutical and biotechnology companies. In addition, Asia Pacific held substantial market share during estimated period owing to soaring need for better diagnostic devices and demand for specialized and quality healthcare facilities to improve patient’s life. Europe held steady growth during predicted period as research laboratories are looking to reduce operational costs and rising adoption of clinical trial imaging techniques in this region. Strategic New Product Launches are the key strategies adopted by market players
Global Clinical Trial Imaging market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, In April 2019, Perspectum Diagnostics launched MRCP+ at the international liver congress which will focus on clinical practices. Key player’s profiles in the report are Bioclinica, Inc., Biomedical Systems Corporation, Biotelemetry, Inc., Cardiovascular Imaging Technologies, LLC, Icon PLC, Intrinsic Imaging LLC, Ixico PLC, Parexel International Corporation, Radiant Sage LLC and Worldcare Clinical, LLC. For More Info, Click here @ https://www.precisionbusinessinsights.com/market-reports/global-clinical-trial-imaging-market/ Detailed Segmentation
By Product & Services
By Modality
By End-User
By Geography North America
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)
About Us: Like it? Share it! More by this author |